Christopher M Jewell
NIH Rank #4521
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Total Funding
$2.2M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#4,521
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2.2M across 3 grants · National rank #4521.
Top grants by award amount
Christopher M Jewell's NIH grant portfolio, ranked by award amount.
- 1R44NS137943-01R44Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)$1.5Maward amount
- 5R01AI169686-03R01Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots$554.7Kaward amount
- 1U44AI184200-01U44Targeting BCMA+ Cells with RNA-engineered CAR T cells to treat Lupus: A Phase 2 clinical study$149Kaward amount
Affiliations
Institutions that have administered grants for Christopher M Jewell.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardCartesian Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4521
- 2024Entered Top 25% NationallyRanked #4521
- 2024Multi-Institutional ResearchAwards at 2 institutions
Explore further
Find collaborators for Christopher M Jewell
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Cartesian Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →